Inaccurate MDS Submission Due to Medication Misclassification
Summary
The facility failed to accurately submit information into the Minimum Data Set (MDS) assessment system for one resident. The deficiency was identified through staff interviews, record reviews, and facility policy reviews. The facility's policy on conducting accurate resident assessments emphasizes the importance of documenting the resident's medical, functional, and psychosocial status accurately. However, the Registered Nurse MDS Coordinator mistakenly entered Ozempic, a medication prescribed to the resident, as insulin in the MDS assessment. This error occurred because of a misunderstanding by the MDS Coordinator, leading to inaccurate information being submitted into the MDS system. The resident involved in this deficiency was admitted to the facility in 2017 and has diagnoses including Type 2 diabetes mellitus and dementia. The resident's MDS assessment with an Assessment Reference Date of May 31, 2024, incorrectly indicated that the resident received insulin injections, which was not the case. The error was confirmed during interviews with the MDS Coordinator and the Administrator, who acknowledged that Ozempic is not an insulin and should not have been coded as such. The resident's Brief Interview for Mental Status (BIMS) score indicated severe cognitive impairment, which underscores the importance of accurate documentation for appropriate care management.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.